Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.57 |
| ▸ | MASP2 | O00187 | 1/20 | 0.57 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.57 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.57 |
| ▸ | FABP6 | P51161 | 1/20 | 0.53 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.52 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.52 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.52 |
| ▸ | PLK3 | Q9H4B4 | 1/20 | 0.52 |
| ▸ | PLAU | P00749 | 1/20 | 0.50 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.50 |
| ▸ | HTR3B | O95264 | 1/20 | 0.50 |
| ▸ | HTR3A | P46098 | 1/20 | 0.50 |
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.50 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29449363 | 1.00 | MEN1 (0.57) | MEN1KMT2AALDH1A1MASP2NUDT1 | |
| Hydrochloric Acid SCHEMBL6621838 | 0.98 | MEN1 (0.55) | MEN1KMT2AALDH1A1MASP2NUDT1 | |
| Trifluoroacetic Acid SCHEMBL6643067 | 0.83 | FABP6 (0.43) | MEN1KMT2AALDH1A1MASP2NUDT1 | |
| SCHEMBL725354 | 0.83 | PLAU (0.66) | MEN1KMT2AALDH1A1MASP2NUDT1 | |
| SCHEMBL28307753 | 0.83 | MEN1 (0.58) | MEN1KMT2AALDH1A1MAPKAPK2RPS6KA3 | |
| Hydrochloric Acid SCHEMBL6621844 | 0.81 | PLAU (0.63) | MEN1KMT2AALDH1A1MASP2NUDT1 | |
| SCHEMBL28241208 | 0.80 | PLAU (0.45) | MEN1KMT2AALDH1A1MASP2NUDT1 | |
| SCHEMBL18782889 | 0.79 | MAPKAPK2 (0.49) | MEN1KMT2AALDH1A1MAPKAPK2RPS6KA3 | |
| SCHEMBL3035648 | 0.79 | MAPKAPK2 (0.49) | MEN1KMT2AALDH1A1MAPKAPK2RPS6KA3 | |
| SCHEMBL1663309 | 0.79 | MAPKAPK2 (0.49) | MEN1KMT2AALDH1A1MAPKAPK2RPS6KA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117946356-A | Preparation method of benzimidazole/silica-based organic-inorganic hybrid dynamic polyimide material | 江苏海洋大学 | 2024-04-30 | — | — | CN | claimed |
| CN-115897068-B | Flexible high-temperature-resistant piezoelectric material and preparation method and application thereof | 天津工业大学 | 2023-09-29 | — | — | CN | claimed |
| CN-114591503-B | Soluble poly (benzimidazole-co-imide) polymer and preparation and application thereof | 中国科学院大连化学物理研究所 | 2023-07-25 | — | — | CN | claimed |
| CN-115897068-A | Flexible high-temperature-resistant piezoelectric material and preparation method and application thereof | 天津工业大学 | 2023-04-04 | — | — | CN | claimed |
| CN-114976047-A | Catalyst for methanol electrooxidation and preparation method thereof | 南京大学 | 2022-08-30 | — | — | CN | claimed |
| CN-113817158-B | Preparation method of high-temperature-resistant nylon resin | 浙江新力新材料股份有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-113817158-A | Preparation method of high-temperature-resistant nylon resin | 浙江新力新材料股份有限公司 | 2021-12-21 | — | — | CN | claimed |
| EP-3105210-A1 | BENZIMIDAZOL-2-AMINES AS MIDH1 INHIBITORS | Bayer Pharma Aktiengesellschaft (DE) | 2016-12-21 | — | — | EP | claimed |
| WO-2015121209-A1 | BENZIMIDAZOL-2-AMINES AS MIDH1 INHIBITORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2015-08-20 | — | — | WO | claimed |
| EP-1576093-A4 | 3-DEOXYGLUCOSONE AND SKIN | DYNAMIS THERAPEUTICS INC (US) | 2009-07-08 | — | — | EP | claimed |
| EP-1753861-A2 | FRUCTOSEAMINE 3 KINASE AND THE FORMATION OF COLLAGEN AND ELASTIN | Dynamis Therapeutics, Inc. (US) | 2007-02-21 | — | — | EP | claimed |
| EP-1576093-A2 | 3-DEOXYGLUCOSONE AND SKIN | Dynamis Therapeutics, Inc. (US) | 2005-09-21 | — | — | EP | claimed |
| WO-2005079463-A2 | FRUCTOSEAMINE 3 KINASE AND THE FORMATION OF COLLAGEN AND ELASTIN | DYNAMIS THERAPEUTICS, INC. (US) | 2005-09-01 | — | — | WO | claimed |
| US-20050159383-A1 | Administering enzyme inhibitors; wrinkling and aging resistance; prevents formation Advanced Glycation End Products (AGEs) | DYNAMIS THERAPEUTICS, INC. | 2005-07-21 | — | — | US | claimed |
| WO-2005007083-A2 | CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-01-27 | — | — | WO | claimed |
| EP-1487824-A1 | DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2004-12-22 | — | — | EP | claimed |
| US-20030219440-A1 | 3-deoxyglucosone and skin | DYNAMIS THERAPEUTICS, INC. | 2003-11-27 | — | — | US | claimed |
| WO-2003089601-A2 | 3-DEOXYGLUCOSONE AND SKIN | DYNAMIS THERAPEUTICS, INC. (US) | 2003-10-30 | — | — | WO | claimed |
| WO-2003074515-A1 | DIAMINO-PYRIMIDINES AND THEIR USE AS ANGIOGENESIS INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2003-09-12 | — | — | WO | claimed |
| US-4321363-A | Adsorbent for urokinase containing agarose | NIPPON SODA COMPANY LIMITED (JP) | 1982-03-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030219440-A1 | 3-deoxyglucosone and skin | DPM1, G6PD, UGGT1 | MEN1 1559/4885KMT2A 3495/4885ALDH1A1 383/4885 |
| US-20050159383-A1 | Administering enzyme inhibitors; wrinkling and aging resistance; prevents formation Advanced Glycation End Products (AGEs) | AGER, GLA, GALE | MEN1 3627/4885KMT2A 2646/4885ALDH1A1 357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.